Samlyn Capital, LLC Iveric Bio, Inc. Transaction History

Samlyn Capital, LLC

  • $5.62 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$18.67 - $24.56 $297,002 - $390,700
15,908 Added 1.06%
1,517,783 $36.9 Million
Q4 2022

Feb 14, 2023
BUY
$17.24 - $23.95 $5.2 Million - $7.22 Million
301,389 Added 25.11%
1,501,875 $32.2 Million
Q3 2022

Nov 14, 2022
BUY
$9.4 - $18.59 $11.3 Million - $22.3 Million
1,200,486 New
1,200,486 $21.5 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Samlyn Capital, LLC Portfolio

Follow Samlyn Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email